- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00580996
Water and the Gastropressor Response - Tachyphylaxis
September 20, 2023 updated by: Satish R. Raj
Water and the Gastropressor Response - Tachyphylaxis (Specific Aim 1.2)
We are studying the effects of oral water ingestion in patients with orthostatic hypotension.
In this study, we are testing the null hypothesis that the blood pressure increase with oral water ingestion will not be diminished if a full prior water dose is given a few hours earlier.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
We are studying the effects of oral water ingestion in patients with orthostatic hypotension.
This has been termed the Gastropressor Response.
In this study, we are testing the null hypothesis that the blood pressure increase with oral water ingestion will not be diminished if a full prior water dose is given a few hours earlier.
In this 2 day study, subjects will be asked to drink with 1 oz or 16 oz of water in the morning followed a few hours later by 16 oz water while the blood pressure is monitored.
On the 2nd day, the other dose of water will be given to start, with 16 oz again as the second dose.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- orthostatic hypotension (fall in BP>20/10 mmHg)
- pressor response to water in other studies
- Age 18-80 years
Exclusion Criteria:
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
16 oz water in AM
|
water 16 oz PO x 1
|
Active Comparator: 2
water 1 oz in AM
|
water 1 oz PO x 1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
blood pressure
Time Frame: 2nd water intervention
|
2nd water intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
heart rate
Time Frame: 2nd intervention
|
2nd intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Satish R Raj, MD MSCI, Vanderbilt University Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2006
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
December 22, 2007
First Submitted That Met QC Criteria
December 22, 2007
First Posted (Estimated)
December 27, 2007
Study Record Updates
Last Update Posted (Actual)
September 21, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 060547
- Vanderbilt Discovery
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthostatic Hypotension
-
Seoul National University HospitalCompletedOrthostatic; Hypotension, NeurogenicKorea, Republic of
-
James J. Peters Veterans Affairs Medical CenterCompleted
-
H. Lundbeck A/SCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Rigshospitalet, DenmarkCompletedPostoperative Orthostatic Hypotension | Postoperative Orthostatic IntoleranceDenmark
-
ShireCompletedSymptomatic Orthostatic HypotensionUnited States, Poland, Czechia, Slovakia
-
Chelsea TherapeuticsCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Hackensack Meridian HealthWithdrawnNeurogenic Orthostatic HypotensionUnited States
-
Seoul National University HospitalKyung Hee University Hospital at GangdongCompletedNeurogenic Orthostatic HypotensionKorea, Republic of
-
National Institute of Neurological Disorders and...Completed
-
Vanderbilt University Medical CenterNYU Langone HealthCompletedNeurogenic Orthostatic HypotensionUnited States
Clinical Trials on water high dose
-
USDA Grand Forks Human Nutrition Research CenterCompletedOverweightUnited States
-
Essentia Water, LLCHealth Onvector Inc.Completed
-
Imam Abdulrahman Bin Faisal UniversityThe Saline Water Conversion Corporation Research Institute at Al-Jubail,...CompletedDiabetes Mellitus | Glucose, High Blood | PatientsSaudi Arabia
-
Oxford Brookes UniversitySuntory Beverage & Food LimitedCompleted
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedAutosomal Dominant Polycystic KidneyUnited States
-
Beijing Northland Biotech. Co., Ltd.CompletedAcute Myocardial InfarctionChina
-
National Institute of Diabetes and Digestive and...Washington University School of Medicine; University of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai and other collaboratorsCompletedEnd Stage Renal DiseaseUnited States
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
Beijing Northland Biotech. Co., Ltd.CompletedSafety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.InfarctionAcute Myocardial InfarctionChina
-
Baylor College of MedicineNeuroMetrix, Inc.RecruitingPain | Neuropathy | Chemotherapy-induced Peripheral NeuropathyUnited States